ArticleOncology and therapy2024

Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort Study.

Miroslawa Püsküllüoğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.